Dr. Reema Jaffar is the Director of Gastroenterology Pathology with QDx Pathology where she joined the pathology team more than six years ago. She received her medical degree from Jawaharial Nehru Medical College Aligarh Muslim University, Aligarh, India. Dr. Jaffar received her Anatomic and Clinical Pathology residency training at Umass Memorial Medical Center in Worchester, MA. She received her fellowship training in Pediatric and Perinatal Pathology at Children’s Memorial Hospital in Chicago, IL. She received her Gastrointestinal and Surgical Pathology Fellowship training at McGaw Medical Center of Northwestern University in Chicago IL. With more than 11 years of experience, Dr. Jaffar’s specialties include Gastroenterology and Pediatrics Pathology. She is board certified in Anatomic Pathology and Clinical Pathology by the American Board of Pathology.

On International Women’s Day 2023, QDx Pathology Services is honored to feature Dr. Jaffar’s background and contributions to pathology

Q: Why pathology? What drives your passion to practice pathology or what initially intrigued you about studying and committing to a career in pathology?
A: “It’s genetic and I have the mutation! My mom is a pathologist and so is my sister. I have always loved science. Med school opened many avenues, but I was drawn towards Pathology because it is a science that provides a definitive answer. It helps in narrowing a broad differential diagnosis. I am an amateur artist and find it easy to remember different patterns of disease in tissues. With the help of lab tests and biopsy results,  I can aid the physician in patient care and treatment. I find it to be a very satisfying and rewarding role for me in health care.”

Q: Please share one of your most memorable cases:
A: “Warning: sad case. During my fellowship, I read the colon biopsies on a 34-year-old young man as malignant. I called the physician to see if there was a mistake with the age. The physician confirmed the age and said that his mother had died young from a stomach malignancy. His father had also died of a malignancy. His sibling was a cancer survivor. That was my first case of Lynch Syndrome. The MMR panel came back deficient. I was able to provide critical information to this family that would change his chemotherapy and give him a better chance to fight the cancer.”

San Francisco, CA

May 19-21, 2019 San Diego, CA

The Premier GI Clinical Meeting & Postgraduate Course
October 25-30, 2019

QDx Pathology is pleased to announce FDA emergency use authorization for testing of at-home, self-collected SARS-CoV-2 samples when ordered by a provider. (FDA-EUA20366).

READ THE LETTER

Written by Staff Reporter

NEW YORK — The US Food and Drug Administration on Tuesday granted separate Emergency Use Authorizations for SARS-CoV-2 tests developed by QDx Pathology Services and Biocan Diagnostics.

The QDx SARS-CoV-2 Assay is a RT-PCR-based assay designed to detect the N gene of the virus in nasal swab specimens self-collected using the Cranford, New Jersey-based medical lab’s Qdetect home collection kit or other authorized home collection kits. It is performed using ChromaCode’s HDPCR SARS-CoV-2 assay, which received EUA from the FDA in June, and may only be performed in QDx’s CLIA-certified lab.

Biocan’s Tell Me Fast Novel Coronavirus IgG/IgM Antibody Test is an immunochromatography-based lateral flow assay designed to detect immunoglobulin G and M antibodies against SARS-CoV-2 in serum, plasma, and venous whole blood samples. Results are provided within 15 minutes, according to the British Columbia, Canada-based company.

The test may be used by any lab CLIA-certified to perform moderate- or high-complexity tests.

SEE ARTICLE

CRANFORD – The Township is working with QDX Pathologies Labs and Immediate Care to operate a COVID-19 testing site for Cranford residents.

The mobile site will open on Wednesday, and is located in the Cranford Community Center/Library parking lot, 220 Walnut Avenue. Hours of operation will be:

Wednesdays 1 to 7 p.m. and Saturdays 9 a.m. to 3 p.m. Appointments are suggested, but walk-ins are also welcomed. Appointments are available at https://www.solvhealth.com/book-online/gwo1Bg

SEE ARTICLE

Edison, N.J. (Apr. 12, 2021)—QDx Pathology Services, a national, independent full-service anatomical and molecular pathology laboratory, is moving all operational components to a new office space in Edison, New Jersey’s Federal Business Center in April, doubling their square footage as a result of QDx’s exponential growth over the past four years. Cushman & Wakefield, a global commercial real estate services firm, served as the broker for the new space.

“Since 2017, our company has grown from under 100 employees to 240 team members and counting,” says Debbie Pacyna, Senior Vice President of Laboratory Services at QDx. “Our new space will undoubtedly improve operations and enhance our stellar customer service wing. The QDx team worked incredibly hard last year to meet the needs of a global pandemic while continuing to serve our core customers, and this stunning new space is a testament to their dedication and drive.”

QDx’s new office will occupy almost 40,000 square feet, a substantial increase from the previous lab’s 20,000 square feet, and will feature a total of six brand new laboratories with expanded technology. These labs will be dedicated to various pathological practices including anatomical, molecular and next-generation-sequencing. Thanks in part to the lab’s larger footprint and an “innovation room,” in which staff pathologists will refine and develop products, several brand-new molecular tests will be available to clients during 2021.

QDx redesigned the space with both clients and employees in mind. Team members will enjoy an innovation room, mother’s room, meditation room, locker rooms with showers, an expanded break room and large dining hall.

QDx Pathology Services, founded in 2006, is led by M. Nasar Qureshi, M.D., Ph.D., a recognized leader in the industry for diagnostic excellence. He completed his professional training at Tulane University School of Medicine, Mount Sinai Hospital, Beth Israel Medical Center and North Shore University Hospital in virology and immunology. Dr. Qureshi specializes in clinical and anatomical pathology.

QDx offers COVID-19 tests, molecular UTI panel, comprehensive gastrointestinal solutions, uropathology, women’s health testing as well as hereditary cancer testing.

QDx’s new office is located at 300 Columbus Circle in Edison, New Jersey at the Federal Business Center, located near the intersection of I-95 and I-440. To learn more or contact QDx, visit qdxpath.com.

About QDX Pathology Services

QDx Pathology Services is a privately-held, CLIA-certified facility located in Central New Jersey, serving medical professionals throughout the country. Its mission is to deliver diagnostic excellence and accuracy for every patient utilizing the latest, state-of-the-art instrumentation and medical technology. QDx offers healthcare providers direct access to its highly experienced, board-certified pathology staff which averages 15 years of experience.

SEE OFFICIAL PRESS RELEASE

Inc. Magazine Reveals Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000

NEW YORK–(BUSINESS WIRE)–Inc. magazine revealed that QDx Pathology Services is No. 2870 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

Click to read the full press release here